Back to top
more

AMERISAFE (AMSF)

(Delayed Data from NSDQ)

$54.95 USD

54.95
116,361

+1.14 (2.12%)

Updated Nov 5, 2024 04:00 PM ET

After-Market: $54.91 -0.04 (-0.07%) 7:52 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value F Growth B Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 7% (18 out of 250)

Industry: Insurance - Accident and Health

Zacks News

Can Amerisafe Grow on the Back of Rising Net Premiums?

Amerisafe (AMSF) is well poised to rise on solid net premiums growth.

Amerisafe (AMSF) Down 0.5% Since Last Earnings Report: Can It Rebound?

Amerisafe (AMSF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

    Amerisafe (AMSF) Tops Q2 Earnings and Revenue Estimates

    Amerisafe (AMSF) delivered earnings and revenue surprises of 26.03% and 3.55%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

      Insurance Stocks Poised to Emerge Winners in Q2 Earnings

      Lower cat loss, pricing gains, increasing interest rate environment and solid capital levels should aid insurers' Q2 earnings.

        AIG to Report Q2 Earnings: Is Disappointment in Store?

        AIG's earnings should suffer from underwriting loss as it is taking several initiatives for business realignment.

          Tanuka De headshot

          Accident and Health Insurers Outlook: High Medical Costs Hurt

          Accident and Health Insurance industry should benefit from strengthening of economy, fueling demand for workers' compensation insurance. However, increasing medical costs pose a challenge.

            Can Nasdaq (NDAQ) Keep Earnings Beat Streak Alive in Q2?

            Nasdaq's (NDAQ) second quarter is likely to benefit from improvement in trading business.

              Will Aflac's (AFL) Earnings Suffer From Weak Japan Revenue?

              Aflacs (AFL) Q2 earnings set to gain from higher U.S segment revenues, partly offset by lower Japan revenues and high costs.

                AMERISAFE & Units Receive Rating Actions From A.M. Best

                A.M. Best revises the credit ratings of AMERISAFE (AMSF) and its subsidiaries along with updated outlooks.

                  Unum Group (UNM) Q1 Earnings Miss Estimates, Revenues Beat

                  Unum Group (UNM) Q1 earnings gain traction from higher premiums, stable benefits experience and a lower tax rate.

                    Amerisafe (AMSF) Q1 Earnings Top Estimates on Lower Expenses

                    Amerisafe's (AMSF) Q1 earning upside was driven by an increase in net investment income and a decline in total expenses.

                      Why Is AMERISAFE (AMSF) Down 6.6% Since Its Last Earnings Report?

                      AMERISAFE (AMSF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                        Should You Get Rid of Amerisafe (AMSF) Now?

                        It seems to be a wise decision for investors to drop Amerisafe (AMSF) stock considering its negative estimate revision, price depreciation as well as unfavorable Zacks rank.

                          New Strong Sell Stocks for March 6th

                          Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

                            Amerisafe's (AMSF) Q4 Earnings Miss as Revenues Decline

                            Amerisafe's (AMSF) earnings suffer from a decline in revenues and increase in expenses.

                              Marsh & McLennan (MMC) Q4 Earnings: Is a Beat in Store?

                              Decent performance across segments is likely to drive Marsh & McLennan's (MMC) fourth-quarter results.

                                What's in Store for MetLife (MET) This Earnings Season?

                                MetLife's (MET) earnings should be driven by higher contribution from its U.S. EMEA, Latin America businesses, partly offset by lower net income from the Asia unit.

                                  Will Weak Japan Business Hurt Aflac's (AFL) Q4 Earnings?

                                  Aflac's (AFL) earnings should see a dent from weak Japan business but be partially aided by strength in its U.S. business.

                                    Will Annuities Unit Aid Lincoln National (LNC) Q4 Earnings?

                                    Lincoln National's (LNC) earnings are likely to benefit from higher annuity sales, strong Retirement and Life insurance business.

                                      Aflac (AFL) Hits New 52-Week High: Is More Upside Left?

                                      Aflac (AFL) gains on estimated positive impact of tax reform but further upside seems muted.

                                        Why You Shouldn't Bet Against AMERISAFE (AMSF) Stock

                                        AMERISAFE, Inc. (AMSF) is seeing solid earnings estimate revision activity, and is a great company from a Zacks Industry Rank perspective.

                                          Is Amerisafe (AMSF) a Great Stock for Value Investors?

                                          Is Amerisafe (AMSF) a great pick from the value investor's perspective right now? Read on to know more.

                                            Why the Earnings Streak Will Continue for Amerisafe (AMSF)

                                            Amerisafe (AMSF) boasts a favorable Zacks Rank and a positive Earnings ESP, which is a great sign of a coming earnings beat.

                                              Amerisafe Maintains Niche Position in High Hazard Insurance

                                              Amerisafe's (AMSF) niche presence in workers' compensation insurance market operating high-hazard industries makes it a specialty insurer.

                                                Unum (UNM) Rides High on Growth Prospects: Time to Buy?

                                                Unum (UNM) appears an attractive pick on the back of growth projections and upward estimate revisions.